201 related articles for article (PubMed ID: 23911299)
1. AMOTL2 interaction with TAZ causes the inhibition of surfactant proteins expression in lung cells.
Lucci V; Di Palma T; D'Ambrosio C; Scaloni A; Zannini M
Gene; 2013 Oct; 529(2):300-6. PubMed ID: 23911299
[TBL] [Abstract][Full Text] [Related]
2. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C.
Park KS; Whitsett JA; Di Palma T; Hong JH; Yaffe MB; Zannini M
J Biol Chem; 2004 Apr; 279(17):17384-90. PubMed ID: 14970209
[TBL] [Abstract][Full Text] [Related]
3. Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W
J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387
[TBL] [Abstract][Full Text] [Related]
4. The TTF-1/TAP26 complex differentially modulates surfactant protein-B (SP-B) and -C (SP-C) promoters in lung cells.
Yang MC; Guo Y; Liu CC; Weissler JC; Yang YS
Biochem Biophys Res Commun; 2006 Jun; 344(2):484-90. PubMed ID: 16630564
[TBL] [Abstract][Full Text] [Related]
5. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
6. Angiomotin-like proteins associate with and negatively regulate YAP1.
Wang W; Huang J; Chen J
J Biol Chem; 2011 Feb; 286(6):4364-70. PubMed ID: 21187284
[TBL] [Abstract][Full Text] [Related]
7. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
8. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N
J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107
[TBL] [Abstract][Full Text] [Related]
9. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL
Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866
[TBL] [Abstract][Full Text] [Related]
10. TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner.
Remue E; Meerschaert K; Oka T; Boucherie C; Vandekerckhove J; Sudol M; Gettemans J
FEBS Lett; 2010 Oct; 584(19):4175-80. PubMed ID: 20850437
[TBL] [Abstract][Full Text] [Related]
11. Angiomotin'g YAP into the nucleus for cell proliferation and cancer development.
Hong W
Sci Signal; 2013 Sep; 6(291):pe27. PubMed ID: 24003252
[TBL] [Abstract][Full Text] [Related]
12. Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
Nagashima S; Maruyama J; Kawano S; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
Cancer Sci; 2016 Jun; 107(6):791-802. PubMed ID: 27009852
[TBL] [Abstract][Full Text] [Related]
13. Modular mimicry and engagement of the Hippo pathway by Marburg virus VP40: Implications for filovirus biology and budding.
Han Z; Dash S; Sagum CA; Ruthel G; Jaladanki CK; Berry CT; Schwoerer MP; Harty NM; Freedman BD; Bedford MT; Fan H; Sidhu SS; Sudol M; Shtanko O; Harty RN
PLoS Pathog; 2020 Jan; 16(1):e1008231. PubMed ID: 31905227
[TBL] [Abstract][Full Text] [Related]
14. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.
Kanai F; Marignani PA; Sarbassova D; Yagi R; Hall RA; Donowitz M; Hisaminato A; Fujiwara T; Ito Y; Cantley LC; Yaffe MB
EMBO J; 2000 Dec; 19(24):6778-91. PubMed ID: 11118213
[TBL] [Abstract][Full Text] [Related]
15. YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease.
Wang K; Degerny C; Xu M; Yang XJ
Biochem Cell Biol; 2009 Feb; 87(1):77-91. PubMed ID: 19234525
[TBL] [Abstract][Full Text] [Related]
16. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus.
Komuro A; Nagai M; Navin NE; Sudol M
J Biol Chem; 2003 Aug; 278(35):33334-41. PubMed ID: 12807903
[TBL] [Abstract][Full Text] [Related]
17. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.].
Ishihara E; Nishina H
Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187
[TBL] [Abstract][Full Text] [Related]
18. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
[TBL] [Abstract][Full Text] [Related]
19. PLAGL2 translocation and SP-C promoter activity--a cellular response of lung cells to hypoxia.
Guo Y; Yang MC; Weissler JC; Yang YS
Biochem Biophys Res Commun; 2007 Aug; 360(3):659-65. PubMed ID: 17618602
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members.
Mahoney WM; Hong JH; Yaffe MB; Farrance IK
Biochem J; 2005 May; 388(Pt 1):217-25. PubMed ID: 15628970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
